洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2500112339】The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

基本信息
登记号

ChiCTR2500112339

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-11-12

临床申请受理号

/

靶点

/

适应症

Obesity

试验通俗题目

The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

试验专业题目

The effects of intermittent dieting with ad-libitum intakes on body composition and psychological responses in obese females: a randomized controlled trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1.To investigate whether the incorporation of ad-libitum intakes during dieting serves as a viable weight reduction strategy as compared to the traditional strategy of continuous energy restriction, thereby giving new insight in combating with the global obesity phenomenon; 2.To back up the proposed physiological and psychological benefits of ad-libitum intakes commonly used among the fitness communities with empirical evidence.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

The random number sequence will be generated by an independent statistician using a random number generator software to ensure an unbiased allocation with a 1:1:1 ratio across the groups

盲法

None

试验项目经费来源

The Education University of Hong Kong

试验范围

/

目标入组人数

25

实际入组人数

/

第一例入组时间

2025-11-13

试验终止时间

2026-03-31

是否属于一致性

/

入选标准

untrained obese (BMI >=25) female Chinese adults (age 18-35);

排除标准

pregnancy, lactating women, history of eating disorders, psychological disorders, chronic diseases or other health problems that may affect participation; and are not involved in any dietary approaches for weight management in the past 12 months;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Education University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Education University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用